ASCO 2024: CM901 and EV302 Efficacy and QOL Updates

By The Uromigos - Last Updated: July 10, 2024

Dr. Guru Sonpavde describes the efficacy of chemotherapy with nivolumab in lymph node-only first-line urothelial carcinoma patients, and Tom describes the quality of life data for enfortumab vedotin plus pembrolizumab.

Post Tags:Uromigos-ASCO
Advertisement
Advertisement
Advertisement